Quiz 4

Bempedoic acid is an _____ inhibitor that LDL-C by inhibition of cholesterol synthesis in the liver.

• HMGCoA reductase

• ACL

• ADP

• AMP

Bempedoic acid does not work in skeletal muscle due to absence of enzyme

• ASCVD

• ASCVL1

• ACL

• None of these

State True or False: Bempedoic acid is well studied in ESRD patients.

• True

• False

State True or False: Bempedoic acid is not studied in patients with severe Liver impairment.

• True

• False

Patients taking simvastatin dose > _____mg, consider lowering dose of statin or switching statin.

• 40

• 80

• 20

• 10

State True or False: The incidence of new-onset or worsening diabetes was lower in the bempedoic acid group than in the placebo group

• True

• False

Clear Tranquility trial involved patients of

• Diabetes Mellitus & Hypertension

• ASCVD

• Heterozygous Familial hypercholesterolemia

• None of these

Indication/s to prescribe Bempedoic acid is/are

• As an adjunct to diet

• maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia

• established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.

• All of these

Secondary dyslipidemia refers to abnormal lipid levels that are caused by a mutated gene or genes inherited from one or both parents.

• True

• False

As per data, A fixed dose combination of bempedoic acid and ezetimibe is capable of providing LDL-C reduction by ___%

• 20

• 30

• 38

• 40